Nebenwirkungen · Optison
OPTISON 0.19 mg/ml dispersion for injection · Abschnitt 4.8 · PDF-Seite 4
HOS-087780 · Präparat HOS-083547
In clinical trials with OPTISON, undesirable effects were reported as adverse events with the following frequencies given in the table below: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2022-06-27T16:57:00Z · SHA-256 9e1f2b7218810ef2caf16bfc26bbe904b753cbc6ffa65a570009b7f38116d8b9 · Passage 01d59cbdae4599a9e4ebd2db1af7688425fc946f36fac1cb0f0f2f0cd68a6fc6 · Zeichen 482–913 im Abschnitt